Intra-Cellular Therapies Vs. Neurogene Industry Stock Comparison

Buy

64

ITCI
Intra-Cellular Therapies

Last Price:

88.20

Seasonality Move:

23.19%

Sell

13

NGNE
Neurogene

Last Price:

39.61

Seasonality Move:

50.43%

Buy

64

Intra-Cellular Therapies (ITCI) is a Buy

Is Intra-Cellular Therapies a Buy, Sell or Hold?

The current Intra-Cellular Therapies [ITCI] share price is $88.21. The Score for ITCI is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
ITCI is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

Sell

13

Neurogene (NGNE) is a Sell

Is Neurogene a Buy, Sell or Hold?

The current Neurogene [NGNE] share price is $39.54. The Score for NGNE is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
NGNE is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
This Score is currently showing an extreme reading that indicates risk could be especially high.

ITCI Stock Price Chart

What is Intra-Cellular Therapies's stock price today?

The Intra-Cellular Therapies share price today is $88.21
The current trend is moderately bullish and ITCI is experiencing slight selling pressure.

NGNE Stock Price Chart

What is Neurogene's stock price today?

The Neurogene share price today is $39.54
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NGNE is experiencing selling pressure, which indicates risk of future bearish movement.

ITCI Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	4	Buy
Relative Strength Index (14 RSI):	66.02	Buy
Chaikin Money Flow:	-336676	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(74.72 - 87.8)	Buy
Bollinger Bands (100):	(71.4 - 81.28)	Buy

NGNE Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	2.3	Buy
Relative Strength Index (14 RSI):	39.1	Sell
Chaikin Money Flow:	-346626	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(43.29 - 61.53)	Sell
Bollinger Bands (100):	(34.11 - 50.51)	Sell

ITCI Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	89.37	Sell
20-day SMA:	83.01	Buy
50-day SMA:	77.64	Buy
200-day SMA:	72.74	Buy
8-day EMA:	88.34	Sell
20-day EMA:	84.33	Buy
50-day EMA:	79.68	Buy
200-day EMA:	72.83	Buy

NGNE Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	60.39	Sell
20-day SMA:	53.17	Sell
50-day SMA:	46.66	Sell
200-day SMA:	38.93	Buy
8-day EMA:	54.03	Sell
20-day EMA:	53.18	Sell
50-day EMA:	48.36	Sell
200-day EMA:	38.47	Buy

Intra-Cellular Therapies Earnings Growth & ITCI Earnings Dates

Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.96 per share, and an increase next year of $0.91 per share.

Neurogene Earnings Growth & NGNE Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.90 per share.

Intra-Cellular Therapies Technical Analysis

	Oct 31	Nov 1	Nov 4	Nov 5	Nov 6	Nov 7	Nov 8	Nov 11	Nov 12	Nov 13
	Oct		Nov
	31	01	04	05	06	07	08	11	12	13
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Neurogene Technical Analysis

	Oct 31	Nov 1	Nov 4	Nov 5	Nov 6	Nov 7	Nov 8	Nov 11	Nov 12	Nov 13
	Oct		Nov
	31	01	04	05	06	07	08	11	12	13
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):